发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 240 |
| England | 89 |
| Australia | 68 |
| Canada | 61 |
| France | 59 |
| Netherlands | 50 |
| GERMANY (FED REP GER) | 47 |
| Italy | 46 |
| Belgium | 36 |
| NORTHERN IRELAND | 28 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF TORONTO | 43 |
| IMPERIAL COLLEGE LONDON | 39 |
| UNIVERSITY OF WASHINGTON | 39 |
| CASE WESTERN RESERVE UNIVERSITY | 33 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 30 |
| CYSTIC FIBROSIS FOUNDATION | 30 |
| UNIVERSITY OF COLORADO SYSTEM | 30 |
| HOSPITAL FOR SICK CHILDREN (SICKKIDS) | 29 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 28 |
| SEATTLE CHILDREN'S HOSPITAL | 28 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| ECFS best practice guidelines: the 2018 revision | 73 |
| CFTR modulator theratyping: Current status, gaps and fut... | 33 |
| Up-to-date and projected estimates of survival for peopl... | 30 |
| Lung transplant referral for individuals with cystic fib... | 22 |
| Multicentre standardisation of chest MRI as radiation-fr... | 17 |
| Lumacaftor/ivacaftor in patients with cystic fibrosis an... | 17 |
| Animal and model systems for studying cystic fibrosis | 15 |
| Isogenic cell models of cystic fibrosis-causing variants... | 14 |
| Epidemiology of CF: How registries can be used to advanc... | 13 |
| Predictive factors for lumacaftor/ivacaftor clinical res... | 13 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J CYST FIBROS | 406 |
| PEDIATR PULM | 362 |
| SEMIN RESP CRIT CARE | 192 |
| COCHRANE DB SYST REV | 157 |
| EXPERT REV RESP MED | 99 |
| SCI REP-UK | 74 |
| NUTR CLIN PRACT | 61 |
| CURR OPIN PULM MED | 57 |
| ANN AM THORAC SOC | 48 |
| FRONT PHARMACOL | 45 |